Siren LLC’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-19,651
Closed -$332K 121
2024
Q3
$332K Buy
+19,651
New +$332K 0.02% 107